Watts R W, Calne R Y, Rolles K, Danpure C J, Morgan S H, Mansell M A, Williams R, Purkiss P
Lancet. 1987 Aug 29;2(8557):474-5. doi: 10.1016/s0140-6736(87)91791-0.
A patient with primary hyperoxaluria type 1 (hepatic peroxisomal alanine:glyoxylate aminotransferase [EC 2.6.1.44] deficiency) was successfully treated by combined hepatic and renal transplantation. The metabolic lesion was corrected by replacement of the deficient hepatic enzyme activity.